| 1 | 668270-12-0 | 利拉利汀 | Linagliptin | C25H28N8O2
| 对照品;糖尿病;中间体;原料药;蛋白酶;标准品;其他杂环;医药原料;利拉利汀;医用原料 | |
| 2 | 2463617-43-6 | 利格列汀杂质6 | 2463617-43-6 | C25H28N8O2
| | |
| 3 | 2140263-92-7 | 利拉利汀杂质 | Linagliptin iMpurity | C25H28N8O2
| 杂质对照品;原料药杂质;内分泌和代谢;内分泌和代谢系统;新药杂质分析检测;对照品-杂质对照品 | |
| 4 | 668270-11-9 | 利拉利汀杂质G | Linagliptin iMpurity G | C25H28N8O2
| 杂质对照品;利格列汀杂质;044-利格列汀;对照品-杂质对照品 | 对照品-杂质对照品;利格列汀杂质;杂质对照品;044-利格列汀 |
| 5 | 668269-51-0 | 利拉利汀杂质3 | (S)-8-(3-aMinopiperidin-1-yl)-7-(but-2-ynyl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione | C25H28N8O2
| 对照品-杂质对照品 | |
| 6 | 2446799-72-8 | 利格列汀杂质16 | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-6H-purin-6-one | C25H28N8O2
| 044-利格列汀 | 044-利格列汀 |
| 7 | 2253964-85-9 | 7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-[(3S)-3-piperidinylamino]-1H-purine-2,6-dione | 7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-[(3S)-3-piperidinylamino]-1H-purine-2,6-dione | C25H28N8O2
| | |
| 8 | 2514724-20-8 | 2H-Purin-2-one, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-6-[(4-methyl-2-quinazolinyl)methoxy]- | 2H-Purin-2-one, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-6-[(4-methyl-2-quinazolinyl)methoxy]- | C25H28N8O2
| | |